PMID: 16506350Mar 2, 2006Paper

Pharmacotherapy for idiopathic pulmonary arterial hypertension during the past 25 years

Pharmacotherapy
Anna M Hackman, Thomas E Lackner

Abstract

To review the current pharmacotherapy for idiopathic pulmonary arterial hypertension (IPAH). A search of the primary literature was conducted by using MEDLINE, the National Institutes of Health medical research Web site (www.clinicaltrials.gov), and the United States Food and Drug Administration's Center for Drug Evaluation and Research Web site (www.fda.gov/cder). Until the early 1980s, conventional therapy for IPAH consisted of anticoagulation, diuretics, digitalis extracts, and supplemental oxygen, yet the 5-year mortality rate remained at 66%. Calcium channel blocker therapy was introduced with the hope that it would improve survival in patients with IPAH, but it was found to be effective in only approximately 25% of patients. In 1996, intravenous epoprostenol was the first drug to show long-term benefit on hemodynamics, exercise capacity, and survival. However, administration of epoprostenol requires a permanently indwelling central venous catheter, and tachyphylaxis is common, necessitating continuous dosage escalations. Subsequently, treprostinil, a prostacyclin analog of epoprostenol that can be administered by continuous subcutaneous infusion, was introduced, followed by aerosolized iloprost, a prostacyclin analog for ...Continue Reading

References

Jul 9, 1992·The New England Journal of Medicine·B W ChristmanJ E Loyd
Aug 1, 1987·Annals of Internal Medicine·S RichS K Koerner
Jun 3, 1982·The New England Journal of Medicine·M PackerH Dash
Nov 1, 1981·Annals of Internal Medicine·M L Cohen, I Kronzon
Oct 1, 1981·British Heart Journal·J Buch, A Wennevold
Jul 1, 1993·Chest·L J Rubin
Jun 17, 1993·The New England Journal of Medicine·A GiaidD J Stewart
Feb 1, 1996·The New England Journal of Medicine·R J BarstUNKNOWN Primary Pulmonary Hypertension Study Group
May 1, 1996·Annals of Internal Medicine·H OlschewskiW Seeger
Nov 1, 1996·The European Respiratory Journal·M P KneusslF P Brenot
Jan 27, 1999·Pulmonary Pharmacology & Therapeutics·M R MacLean
May 13, 1999·The Annals of Thoracic Surgery·R I WhyteB A Reitz
Sep 25, 1999·The American Journal of Cardiology·A RothmanS W Jamieson
Oct 16, 1999·Journal of the American College of Cardiology·S Rich, V V McLaughlin
Oct 16, 1999·Journal of the American College of Cardiology·N NagayaT Kunieda
Jan 3, 2001·JAMA : the Journal of the American Medical Association·S Gaine
Feb 24, 2001·The New England Journal of Medicine·S PrasadM A Gatzoulis
Jun 19, 2001·Heart·A J Handley
Nov 28, 2001·The Annals of Thoracic Surgery·J V ConteJ B Orens
Mar 19, 2002·American Journal of Respiratory and Critical Care Medicine·Gerald SimonneauUNKNOWN Treprostinil Study Group
Mar 22, 2002·The New England Journal of Medicine·Lewis J RubinGerald Simonneau
Apr 3, 2002·Annals of Internal Medicine·Hossein Ardeschir GhofraniFriedrich Grimminger
May 3, 2002·Journal of the American College of Cardiology·Nazzareno GalièUNKNOWN Arterial Pulmonary Hypertension and Beraprost European (ALPHABET) Study Group
Jul 26, 2002·The New England Journal of Medicine·Brett N Pereira, Sundeep Salvi
Aug 2, 2002·The New England Journal of Medicine·Horst OlschewskiUNKNOWN Aerosolized Iloprost Randomized Study Group
Sep 18, 2002·Circulation·Vallerie V McLaughlinStuart Rich

❮ Previous
Next ❯

Citations

Jan 1, 2010·Drug, Healthcare and Patient Safety·Mitchell S BuckleyJeremy P Feldman
Nov 8, 2014·Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society·Martha S Kingman, Sandra Lombardi
Aug 21, 2015·Expert Opinion on Pharmacotherapy·Swanny PerrinOlivier Sitbon
Apr 12, 2013·The American Journal of Cardiology·Hunter C Champion
Sep 4, 2007·Trends in Endocrinology and Metabolism : TEM·Michelle A CareyDarryl C Zeldin
Aug 3, 2012·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Amaris FuentesKyle L Dawson
Dec 3, 2014·European Respiratory Review : an Official Journal of the European Respiratory Society·Luke S HowardSanjay Mehta
Feb 9, 2008·Drugs·Katherine F Croom, Monique P Curran

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.